Related Experiment Video
Updated: Jul 30, 2025
06:01
Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions
Published on: January 7, 2019
7.3K
Discovery of a Hidden Proinflammatory Signaling Proteome Using a Large-Scale, Targeted Antibody Microarray Platform
Catherine Jozwik1, Ofer Eidelman1, Meera Srivastava2
1Department of Anatomy, Physiology and Genetics, and Institute for Molecular Medicine, Uniformed Services University School of Medicine (USUHS), Bethesda, MD, USA.
Methods in Molecular Biology (Clifton, N.J.)
|May 16, 2023
Summary
This study introduces a new antibody microarray method to measure protein synthesis and degradation rates in lung cells. This technique reveals hidden protein changes in cystic fibrosis (CF) cells, offering new insights into disease mechanisms.
Area of Science:
- Molecular Biology
- Proteomics
- Cell Biology
Background:
- Protein expression in eukaryotic cells is regulated by dynamic post-translational processes.
- Conventional proteomic technologies struggle to assess individual protein biosynthesis and degradation rates, as they only measure total protein levels.
- These crucial dynamic rates remain hidden from standard proteomic analyses.
Purpose of the Study:
- To develop and demonstrate a novel antibody microarray-based, time-resolved approach.
- To simultaneously measure total protein changes and protein biosynthesis rates for low-abundance proteins.
- To investigate the complete proteomic kinetics in cystic fibrosis (CF) lung epithelial cells and the effects of gene therapy.
Main Methods:
- Utilized a novel antibody microarray-based, time-resolved technique.
- Investigated proteomic kinetics of 507 low-abundance proteins in cultured CF lung epithelial cells.
- Employed 35[S] methionine or 32[P] labeling to track protein synthesis and degradation.
Main Results:
- Successfully measured simultaneous total protein changes and biosynthesis rates of low-abundance proteins.
- Characterized the complete proteomic kinetics of 507 low-abundance proteins in CF lung epithelial cells.
- Identified previously undetected protein regulations influenced by the CF genotype and gene therapy with wildtype CFTR.
Conclusions:
- The novel antibody microarray technology enables the measurement of dynamic protein expression rates.
- This approach uncovers hidden proteomic regulations in CF lung epithelial cells that are missed by conventional methods.
- The findings highlight the utility of this technique for understanding genotype-specific protein regulation and therapeutic interventions.
